$OPK The first COVID-19 diagnostic at-home self-test that provides rapid results has been approved by the U.S. Food and Drug Administration, the agency announced Tuesday. The Lucira COVID-19 All-In-One Test Kit is a molecular single-use test. "While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home," FDA Commissioner Stephen Hahn said in a statement. Hahn added: "This new testing option is an important diagnostic advancement to address the pandemic and reduce the public burden of disease transmission."